BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8978300)

  • 1. Interferon-beta interrupts interleukin-6-dependent signaling events in myeloma cells.
    Berger LC; Hawley RG
    Blood; 1997 Jan; 89(1):261-71. PubMed ID: 8978300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 induces tyrosine phosphorylation of the Ras activating protein Shc, and its complex formation with Grb2 in the human multiple myeloma cell line LP-1.
    Neumann C; Zehentmaier G; Danhauser-Riedl S; Emmerich B; Hallek M
    Eur J Immunol; 1996 Feb; 26(2):379-84. PubMed ID: 8617307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD16-mediated p21ras activation is associated with Shc and p36 tyrosine phosphorylation and their binding with Grb2 in human natural killer cells.
    Galandrini R; Palmieri G; Piccoli M; Frati L; Santoni A
    J Exp Med; 1996 Jan; 183(1):179-86. PubMed ID: 8551221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase.
    Giordano V; De Falco G; Chiari R; Quinto I; Pelicci PG; Bartholomew L; Delmastro P; Gadina M; Scala G
    J Immunol; 1997 May; 158(9):4097-103. PubMed ID: 9126968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of interleukin-2-dependent signal transduction through the Shc/Grb2 adapter pathway. Interleukin-2-dependent mitogenesis does not require Shc phosphorylation or receptor association.
    Evans GA; Goldsmith MA; Johnston JA; Xu W; Weiler SR; Erwin R; Howard OM; Abraham RT; O'Shea JJ; Greene WC
    J Biol Chem; 1995 Dec; 270(48):28858-63. PubMed ID: 7499411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
    Besset V; Scott RP; Ibáñez CF
    J Biol Chem; 2000 Dec; 275(50):39159-66. PubMed ID: 10995764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
    Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.
    Ogata A; Chauhan D; Teoh G; Treon SP; Urashima M; Schlossman RL; Anderson KC
    J Immunol; 1997 Sep; 159(5):2212-21. PubMed ID: 9278309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biphasic activation of p21ras by endothelin-1 sequentially activates the ERK cascade and phosphatidylinositol 3-kinase.
    Foschi M; Chari S; Dunn MJ; Sorokin A
    EMBO J; 1997 Nov; 16(21):6439-51. PubMed ID: 9351826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin activates Raf1 by an Shc-independent pathway in CTLL-EPO-R cells.
    Barber DL; Corless CN; Xia K; Roberts TM; D'Andrea AD
    Blood; 1997 Jan; 89(1):55-64. PubMed ID: 8978277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative signaling in B cells causes reduced Ras activity by reducing Shc-Grb2 interactions.
    Tridandapani S; Chacko GW; Van Brocklyn JR; Coggeshall KM
    J Immunol; 1997 Feb; 158(3):1125-32. PubMed ID: 9013951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flt3 signaling involves tyrosyl-phosphorylation of SHP-2 and SHIP and their association with Grb2 and Shc in Baf3/Flt3 cells.
    Zhang S; Mantel C; Broxmeyer HE
    J Leukoc Biol; 1999 Mar; 65(3):372-80. PubMed ID: 10080542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.
    Kim H; Baumann H
    Mol Cell Biol; 1999 Aug; 19(8):5326-38. PubMed ID: 10409724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of mitogen-activated protein kinase cascade signaling in interleukin 6-independent multiple myeloma cells.
    Ogata A; Chauhan D; Urashima M; Teoh G; Treon SP; Anderson KC
    Clin Cancer Res; 1997 Jun; 3(6):1017-22. PubMed ID: 9815779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taxol induces tyrosine phosphorylation of Shc and its association with Grb2 in murine RAW 264.7 cells.
    Wolfson M; Yang CP; Horwitz SB
    Int J Cancer; 1997 Jan; 70(2):248-52. PubMed ID: 9009167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.
    Tauchi T; Boswell HS; Leibowitz D; Broxmeyer HE
    J Exp Med; 1994 Jan; 179(1):167-75. PubMed ID: 7505797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues.
    Thirone AC; Carvalho CR; Saad MJ
    Endocrinology; 1999 Jan; 140(1):55-62. PubMed ID: 9886807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific involvement of tyrosine 764 of human granulocyte colony-stimulating factor receptor in signal transduction mediated by p145/Shc/GRB2 or p90/GRB2 complexes.
    de Koning JP; Schelen AM; Dong F; van Buitenen C; Burgering BM; Bos JL; Löwenberg B; Touw IP
    Blood; 1996 Jan; 87(1):132-40. PubMed ID: 8547634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ubiquitously expressed Syp phosphatase interacts with c-kit and Grb2 in hematopoietic cells.
    Tauchi T; Feng GS; Marshall MS; Shen R; Mantel C; Pawson T; Broxmeyer HE
    J Biol Chem; 1994 Oct; 269(40):25206-11. PubMed ID: 7523381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways.
    Sasaoka T; Ishiki M; Sawa T; Ishihara H; Takata Y; Imamura T; Usui I; Olefsky JM; Kobayashi M
    Endocrinology; 1996 Oct; 137(10):4427-34. PubMed ID: 8828504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.